United Cannabis Corporation Subsidiary Enters Business Partnership With Harborside Health Center

Companies Will Work Together To Produce and Distribute United Cannabis’ Prana™ and Bubbleman Product Lines To Patients Throughout California

DENVER, CO / ACCESSWIRE / March 28, 2016 / United Cannabis Corporation (OTCQB: CNAB) (the “Company” or “United Cannabis”) today announced that its subsidiary UCANN California Corporation (“UCANN CA”) has entered into a partnership with the Harborside Health Center (“Harborside”), for the production and distribution of the United Cannabis-branded Prana Bio Nutrient Medicinals and its Bubbleman affiliated products in the State of California.

The companies have been working together since United Cannabis established its A.C.T. Now Program in Harborside’s Oakland facility this August. The Advanced Cannabinoid Therapy or “A.C.T.” Now Program was designed to help patients achieve the correct combination of Prana Bio Nutrient Medicinal products as well as provide education and other support for patients managing cancer, autism, seizures, dependency, PTSD, arthritis and other special needs.

The positive patient response to the Program and Prana products were a factor in the move to expand the relationship. The newly signed agreement provides for the extension of the current infrastructure to enable the companies to serve patients statewide.

Under the agreement, Harborside will have an exclusive license to United Cannabis’ intellectual property and utility patent for the manufacture of the entire Prana Bio Nutrient Medicinal line as well as its affiliated Bubbleman products, including Full Melt Bubble Hash, Dry Sift and Flower Rosin. The agreement also provides for Harborside to serve as the exclusive distributor of these products throughout the state of California.

Tony Verzura, United Cannabis’ Chief Technology Officer, commented on the partnership, “We chose to partner with Harborside because Steve and his team run the best medical cannabis operation in the state, if not the country. His mission to serve patients is evident in every aspect of the operation, from the services they provide to the classes they offer to their 100+ team of incredibly knowledgeable budtenders, and we are proud that our products are a part of the organization.”

Mr. Verzura went on to say, “Our successful operation in Harborside provides the blue print for United Cannabis’ continued growth. Scaling the operation from a single facility to a statewide organization is the next step in the execution of our business plan, and one we expect to implement in other states going forward.”

“United Cannabis’ Prana and Bubbleman products facilitate our ability to provide patients with the highest quality of personalized medicine and are a natural extension of the products and services we offer at Harborside. I am pleased with the growth of our relationship, and look forward to working with United Cannabis to bring the benefits of cannabis-based medicine to patients throughout California.” says Steve DeAngelo, Founder of Harborside.

About United Cannabis Corporation

United Cannabis Corporation was founded to provide leadership in the medical cannabis industry by offering patient driven solutions intent on improving biomedical and pharmaceutical pursuits through the use of cannabis-based research, products and services. The Company has established affiliate relationships with Harborside, Prana Bio Nutrient Medicinals, Bubbleman, Blue River, Cannabinoid Research & Development, DNA Genetics, and Emotek. For further information, please visit www.unitedcannabis.us.

About A.C.T. Now*

The A.C.T. Now Program is a robust, holistic program offering a customized combination of 100% plant-derived Prana Bio Medicinals, nutritional guidelines, nursing support, patient education, on-site visitation and electronic medical chart management. Together, these products and services have had a profound effect on patients diagnosed with many severe illnesses.

*These statements have not been evaluated by the FDA

About Harborside Health Center:

“Harborside Health Center, a nonprofit medical marijuana dispensary with locations in Oakland and San Jose, California, is looked upon as a model of how others could operate.” – The New York Times

Founded in 2006 by Steve DeAngelo, Harborside Health Center is the most respected and largest medical cannabis dispensary in the United States. Harborside has over 200,000 registered patients and was first in the nation to support education for seniors, veterans and families with severely ill children; first in the country to offer CBD-rich medicine; and the first to treat children with Dravet syndrome. Harborside continues to set an example of diversity and compliance, and is one of the prime advocates of diversity, sustainability and economic justice in the industry.

DeAngelo also co-founded the nation’s first cannabis-testing facility, Steep Hill Labs, and the country’s first cannabis investment and research firm, The ArcView Group. His book, The Cannabis Manifesto: A New Paradigm for Wellness, is published by North Atlantic Books and distributed by Penguin/Random House. DeAngelo was named one of the most influential people and “gatekeeper” of the marijuana industry in 2015 by the International Business Times, and one of the most influential people in the cannabis industry in 2014 by the Cannabis Business Executive.

Contact: Staff@UnitedCannabis.us

Phone: 303-386-7321

Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933, and are subject to Rule 3B-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and other results and further events could differ materially from those anticipated in such statements. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.

SOURCE: United Cannabis Corporation

ReleaseID: 438189